Name | Number of supported studies | Average coverage | |
---|---|---|---|
fibroblast | 33 studies | 37% ± 15% | |
smooth muscle cell | 18 studies | 42% ± 19% | |
endothelial cell of lymphatic vessel | 15 studies | 31% ± 15% | |
myofibroblast cell | 11 studies | 48% ± 15% | |
endothelial cell | 10 studies | 27% ± 10% | |
pericyte | 7 studies | 29% ± 14% | |
connective tissue cell | 6 studies | 49% ± 20% | |
endothelial cell of artery | 6 studies | 38% ± 19% | |
mesothelial cell | 6 studies | 37% ± 16% | |
adventitial cell | 5 studies | 47% ± 8% | |
adipocyte | 5 studies | 17% ± 2% | |
astrocyte | 4 studies | 24% ± 9% | |
retinal pigment epithelial cell | 3 studies | 24% ± 8% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
prostate | 95% | 18015.49 | 232 / 245 | 95% | 45.39 | 476 / 502 |
pancreas | 90% | 6677.66 | 296 / 328 | 92% | 82.15 | 164 / 178 |
breast | 93% | 15443.52 | 428 / 459 | 82% | 68.80 | 914 / 1118 |
lung | 99% | 34706.42 | 573 / 578 | 74% | 39.72 | 858 / 1155 |
uterus | 95% | 10633.36 | 161 / 170 | 55% | 60.57 | 253 / 459 |
intestine | 77% | 7295.26 | 741 / 966 | 70% | 28.25 | 368 / 527 |
esophagus | 88% | 22283.08 | 1270 / 1445 | 56% | 23.04 | 102 / 183 |
stomach | 68% | 7818.98 | 244 / 359 | 71% | 38.37 | 204 / 286 |
thymus | 83% | 8028.96 | 540 / 653 | 49% | 11.35 | 295 / 605 |
bladder | 76% | 9544.14 | 16 / 21 | 54% | 20.52 | 273 / 504 |
brain | 18% | 1448.55 | 472 / 2642 | 97% | 61.85 | 684 / 705 |
ovary | 54% | 4467.53 | 98 / 180 | 56% | 22.08 | 240 / 430 |
blood vessel | 100% | 104651.19 | 1330 / 1335 | 0% | 0 | 0 / 0 |
adipose | 96% | 19967.57 | 1155 / 1204 | 0% | 0 | 0 / 0 |
skin | 59% | 8772.07 | 1064 / 1809 | 26% | 8.44 | 122 / 472 |
heart | 76% | 13336.51 | 652 / 861 | 0% | 0 | 0 / 0 |
adrenal gland | 11% | 613.20 | 29 / 258 | 63% | 34.93 | 145 / 230 |
spleen | 73% | 5938.57 | 177 / 241 | 0% | 0 | 0 / 0 |
kidney | 13% | 1062.28 | 12 / 89 | 44% | 16.38 | 396 / 901 |
liver | 4% | 180.82 | 8 / 226 | 37% | 14.68 | 149 / 406 |
tonsil | 0% | 0 | 0 / 0 | 40% | 17.46 | 18 / 45 |
lymph node | 0% | 0 | 0 / 0 | 17% | 2.24 | 5 / 29 |
muscle | 9% | 607.69 | 69 / 803 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 1% | 0.13 | 1 / 80 |
peripheral blood | 0% | 27.81 | 3 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0085029 | Biological process | extracellular matrix assembly |
GO_0043149 | Biological process | stress fiber assembly |
GO_0003180 | Biological process | aortic valve morphogenesis |
GO_0003151 | Biological process | outflow tract morphogenesis |
GO_0007519 | Biological process | skeletal muscle tissue development |
GO_0030833 | Biological process | regulation of actin filament polymerization |
GO_0008015 | Biological process | blood circulation |
GO_0048660 | Biological process | regulation of smooth muscle cell proliferation |
GO_0007585 | Biological process | respiratory gaseous exchange by respiratory system |
GO_0009887 | Biological process | animal organ morphogenesis |
GO_0071953 | Cellular component | elastic fiber |
GO_0005576 | Cellular component | extracellular region |
GO_0062023 | Cellular component | collagen-containing extracellular matrix |
GO_0031012 | Cellular component | extracellular matrix |
GO_0005201 | Molecular function | extracellular matrix structural constituent |
GO_0030023 | Molecular function | extracellular matrix constituent conferring elasticity |
GO_0050840 | Molecular function | extracellular matrix binding |
GO_0005515 | Molecular function | protein binding |
Gene name | ELN |
Protein name | Elastin Elastin (Tropoelastin) |
Synonyms | hCG_18037 |
Description | FUNCTION: Major structural protein of tissues such as aorta and nuchal ligament, which must expand rapidly and recover completely. Molecular determinant of the late arterial morphogenesis, stabilizing arterial structure by regulating proliferation and organization of vascular smooth muscle (By similarity). . FUNCTION: Major structural protein of tissues such as aorta and nuchal ligament, which must expand rapidly and recover completely. Molecular determinant of the late arterial morphogenesis, stabilizing arterial structure by regulating proliferation and organization of vascular smooth muscle. . FUNCTION: Major structural protein of tissues such as aorta and nuchal ligament, which must expand rapidly and recover completely. Molecular determinant of the late arterial morphogenesis, stabilizing arterial structure by regulating proliferation and organization of vascular smooth muscle. . FUNCTION: Major structural protein of tissues such as aorta and nuchal ligament, which must expand rapidly and recover completely. Molecular determinant of the late arterial morphogenesis, stabilizing arterial structure by regulating proliferation and organization of vascular smooth muscle. . FUNCTION: Major structural protein of tissues such as aorta and nuchal ligament, which must expand rapidly and recover completely. Molecular determinant of the late arterial morphogenesis, stabilizing arterial structure by regulating proliferation and organization of vascular smooth muscle. . FUNCTION: Major structural protein of tissues such as aorta and nuchal ligament, which must expand rapidly and recover completely. Molecular determinant of the late arterial morphogenesis, stabilizing arterial structure by regulating proliferation and organization of vascular smooth muscle. . FUNCTION: Major structural protein of tissues such as aorta and nuchal ligament, which must expand rapidly and recover completely. Molecular determinant of the late arterial morphogenesis, stabilizing arterial structure by regulating proliferation and organization of vascular smooth muscle. . FUNCTION: Major structural protein of tissues such as aorta and nuchal ligament, which must expand rapidly and recover completely. Molecular determinant of the late arterial morphogenesis, stabilizing arterial structure by regulating proliferation and organization of vascular smooth muscle. . FUNCTION: Major structural protein of tissues such as aorta and nuchal ligament, which must expand rapidly and recover completely. Molecular determinant of the late arterial morphogenesis, stabilizing arterial structure by regulating proliferation and organization of vascular smooth muscle. . FUNCTION: Major structural protein of tissues such as aorta and nuchal ligament, which must expand rapidly and recover completely. Molecular determinant of the late arterial morphogenesis, stabilizing arterial structure by regulating proliferation and organization of vascular smooth muscle. . FUNCTION: Major structural protein of tissues such as aorta and nuchal ligament, which must expand rapidly and recover completely. Molecular determinant of the late arterial morphogenesis, stabilizing arterial structure by regulating proliferation and organization of vascular smooth muscle. . FUNCTION: Major structural protein of tissues such as aorta and nuchal ligament, which must expand rapidly and recover completely. Molecular determinant of the late arterial morphogenesis, stabilizing arterial structure by regulating proliferation and organization of vascular smooth muscle. . FUNCTION: Major structural protein of tissues such as aorta and nuchal ligament, which must expand rapidly and recover completely. Molecular determinant of the late arterial morphogenesis, stabilizing arterial structure by regulating proliferation and organization of vascular smooth muscle. . FUNCTION: Major structural protein of tissues such as aorta and nuchal ligament, which must expand rapidly and recover completely. Molecular determinant of the late arterial morphogenesis, stabilizing arterial structure by regulating proliferation and organization of vascular smooth muscle. . |
Accessions | ENST00000417091.5 E7EQH8 ENST00000442310.5 E7EP82 ENST00000431562.5 E7EWS8 G5E950 ENST00000438906.5 B3KRT8 E7ENW7 ENST00000380576.9 [P15502-13] E7ENM0 ENST00000380562.8 [P15502-1] G3V0G6 E7EN65 ENST00000320399.10 [P15502-4] ENST00000419398.1 H7C3K0 ENST00000416107.5 ENST00000621115.4 ENST00000685240.1 ENST00000428787.5 ENST00000414324.5 ENST00000380553.8 [P15502-11] ENST00000445912.5 A0A8I5QKI6 ENST00000380584.8 [P15502-8] E9PGX4 ENST00000429192.5 [P15502-12] Q9UMK5 ENST00000380575.8 [P15502-7] E7ETP7 ENST00000252034.12 [P15502-2] ENST00000692049.1 [P15502-3] A7L3I8 ENST00000458204.5 ENST00000438880.5 P15502 ENST00000320492.11 Q9UME9 ENST00000357036.9 [P15502-5] E7EN51 |